Aoyama K, Kawashima S, Saeki Y, Kawahara Y, et al. Blockade for CD276-mediated suppression of tumor-specific cytotoxic T lymphocytes may contribute to achieving durable responses with immune checkpoint inhibitors. J Invest Dermatol 2026;146:2554-2564.
PMID: 41833709